… the gut microbiota has become a focus of major interest in the study of inflammatory bowel
disease (IBD) pathogenesis. … of several gut microbiome abnormalities in patients with Crohn’s …

… classical EIM focusing on epidemiology, genetics, and pathogenesis, highlighting recent
advances in the understanding of EIM. We further discuss treatment-induced immunological …

… Inflammatory bowel disease (IBD) is a chronic and life-long disease characterized by
gastrointestinal tract inflammation. It is caused by the interplay of the host’s genetic predisposition …

… uveitis, psoriasis and inflammatory bowel disease (IBD) are frequently observed in the
setting of SpA and are, in fact, part of the SpA classification criteria. Bowel involvement seems to …

… The current understanding of inflammatory bowel disease (IBD) pathogenesis implicates
a complex interaction between host genetics, host immunity, microbiome, and environmental …

… and microbiome on disease pathogenesis and have offered opportunities for disease prevention
by … to provide globally sustainable inflammatory bowel disease care in the 21st century. …

… incidence of inflammatory bowel diseases (IBD) in East has risen over the past decade to
become a global disease. … of the estimated prevalence of inflammatory bowel diseases (IBD) …

… Inflammatory bowel disease (IBD) has become a global disease with accelerating incidence
worldwide in the 21st century while its accurate etiology remains unclear. In the past decade…

… and therapeutic opportunities. The factors previously mentioned as associated with IBD,
ie, the environment, the genes, the microbiota, and the immune systems, may all be critically …

… Depression and anxiety are common comorbidities in inflammatory bowel disease (IBD),
but the prevalence varies across studies owing to heterogeneity in study populations and …